Literature DB >> 6268690

Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.

P Kotulla, H Schleusener.   

Abstract

The usefulness of solubilized TSH-receptor for measuring TSH and TSH-displacing antibodies (TDA) in a radioligand receptor assay (RRA) was investigated. Crude thyroid membranes were solubilized with Triton X-100. A soluble protein fraction was isolated by DEAE-Sephadex A-50 ion-exchange chromatography. The binding of 125I-TSH to the solubilized fraction was studied. It was maximal after 45 min at 37 C, whereas at 4 C a similar binding was observed after at least 17 h. The binding was inhibited by Ca2+ and Mg2+ with concentrations higher than 1 mM and by NaCl in the concentration range 17-150 mM. No inhibition of binding was found with normal serum up to 100 microliter. In contrast, 1.5 microliter of a Graves' disease serum showed significant inhibition. Using the system to measure TSH in serum, as low as 10 microunits TSH could be estimated. Compared to an RRA using thyroid membrane fractions, the sensitivity for TSH in serum as well as for TDA is increased at least tenfold in our system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268690     DOI: 10.1007/BF03350444

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins.

Authors:  G Fenzi; E Macchia; L Bartalena; F Mazzanti; L Baschieri; L J DeGroot
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion.

Authors:  R L Tate; H I Schwartz; J M Holmes; L D Kohn
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

3.  Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes.

Authors:  R L Tate; J M Holmes; L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

4.  Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.

Authors:  J O'Donnell; K Trokoudes; J Silverberg; V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

5.  Existence of a soluble thyrotropin binding component in normal human sera.

Authors:  G Lee; S M Aloj; F Beguinot; L D Kohn
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

6.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

7.  Properties of the insulin receptor isolated from liver and fat cell membranes.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1972-04-10       Impact factor: 5.157

8.  Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  K Endo; K Kasagi; J Konishi; K Ikekubo; T Okuno; Y Takeda; T Mori; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

9.  Properties of the interaction between bovine thyrotropin and bovine thyroid plasma membranes.

Authors:  S M Amir; I D Goldfine; S H Ingbar
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

Review 10.  Immunology of the thyrotropin receptor.

Authors:  B R Smith
Journal:  Immunol Commun       Date:  1976
View more
  2 in total

1.  Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.

Authors:  P Kotulla; C Kostner; H Schleusener
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

2.  TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.

Authors:  E Macchia; G F Fenzi; F Monzani; L Bartalena; F Lippi; V Aloisio; C Cupini; L Baschieri; A Pinchera
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.